- Home
- MCB vs TERN Comparison
MCB vs TERN Comparison
Compare MCB & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCB
- TERN
- Stock Information
- Founded
- MCB 1999
- TERN 2017
- Country
- MCB United States
- TERN United States
- Employees
- MCB N/A
- TERN N/A
- Industry
- MCB Major Banks
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- MCB Finance
- TERN Health Care
- Exchange
- MCB Nasdaq
- TERN Nasdaq
- Market Cap
- MCB 685.1M
- TERN 710.6M
- IPO Year
- MCB 2017
- TERN 2021
- Fundamental
- Price
- MCB $75.34
- TERN $28.75
- Analyst Decision
- MCB Buy
- TERN Buy
- Analyst Count
- MCB 2
- TERN 11
- Target Price
- MCB $82.00
- TERN $25.59
- AVG Volume (30 Days)
- MCB 98.9K
- TERN 5.5M
- Earning Date
- MCB 10-23-2025
- TERN 11-10-2025
- Dividend Yield
- MCB 0.80%
- TERN N/A
- EPS Growth
- MCB 8.50
- TERN N/A
- EPS
- MCB 5.80
- TERN N/A
- Revenue
- MCB $261,456,000.00
- TERN N/A
- Revenue This Year
- MCB $15.57
- TERN N/A
- Revenue Next Year
- MCB $13.99
- TERN N/A
- P/E Ratio
- MCB $12.96
- TERN N/A
- Revenue Growth
- MCB 1.27
- TERN N/A
- 52 Week Low
- MCB $47.08
- TERN $1.87
- 52 Week High
- MCB $81.33
- TERN $29.51
- Technical
- Relative Strength Index (RSI)
- MCB 64.33
- TERN 81.58
- Support Level
- MCB $67.17
- TERN $25.31
- Resistance Level
- MCB $70.46
- TERN $28.49
- Average True Range (ATR)
- MCB 2.01
- TERN 2.00
- MACD
- MCB 1.04
- TERN 0.49
- Stochastic Oscillator
- MCB 91.40
- TERN 94.84
About MCB Metropolitan Bank Holding Corp.
Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.